|
CA2410382A1
(en)
*
|
2000-05-26 |
2002-11-25 |
Nippon Shinyaku Co., Ltd. |
Heterocyclic compounds
|
|
US7399777B2
(en)
*
|
2001-08-31 |
2008-07-15 |
Sanofi-Aventis Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
|
|
US6884812B2
(en)
*
|
2001-08-31 |
2005-04-26 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
|
|
US7078404B2
(en)
*
|
2002-04-11 |
2006-07-18 |
Sanofi-Aventis Deutschland Gmbh |
Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
|
|
US7049341B2
(en)
*
|
2002-06-07 |
2006-05-23 |
Aventis Pharma Deutschland Gmbh |
N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
|
|
US7262220B2
(en)
*
|
2002-07-11 |
2007-08-28 |
Sanofi-Aventis Deutschland Gmbh |
Urea- and urethane-substituted acylureas, process for their preparation and their use
|
|
US7208504B2
(en)
|
2002-10-12 |
2007-04-24 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic inhibitors of hormone sensitive lipase
|
|
DE10258008B4
(de)
*
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
DE10258007B4
(de)
*
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
US20040242583A1
(en)
*
|
2003-01-20 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
|
|
US7179941B2
(en)
|
2003-01-23 |
2007-02-20 |
Sanofi-Aventis Deutschland Gmbh |
Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
|
|
US7196114B2
(en)
*
|
2003-02-17 |
2007-03-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
|
|
US7094795B2
(en)
|
2003-02-27 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
|
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE10308350B4
(de)
*
|
2003-02-27 |
2006-06-01 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
|
|
DE10308352A1
(de)
|
2003-02-27 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
DE10308355A1
(de)
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
DE10308353A1
(de)
*
|
2003-02-27 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7173151B2
(en)
*
|
2003-02-27 |
2007-02-06 |
Sanofi-Aventisdeutschand Gmbh |
Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
|
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
|
US7501440B2
(en)
*
|
2003-03-07 |
2009-03-10 |
Sanofi-Aventis Deutschland Gmbh |
Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
|
|
US6989462B2
(en)
|
2003-03-25 |
2006-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Synthesis of 2-chloromethyl-6-methylbenzoic ester
|
|
DE10313228A1
(de)
*
|
2003-03-25 |
2004-10-21 |
Aventis Pharma Deutschland Gmbh |
Synthese von 2-Chlormethyl-6-methylbenzoesäureestern
|
|
DE10314610A1
(de)
*
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
|
CA2525367A1
(en)
*
|
2003-05-09 |
2004-11-25 |
The Trustees Of The University Of Pennsylvania |
Use of citrate lyase inhibitors and tricarboxylate transporter inhibitors in the treatment of cancer
|
|
CA2525302A1
(en)
*
|
2003-05-12 |
2004-11-18 |
David Bundle |
Multivalent inhibitors of serum amyloid p component
|
|
US7008957B2
(en)
*
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
|
US7094800B2
(en)
*
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
|
US7094794B2
(en)
*
|
2003-07-28 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
|
|
DE10335092B3
(de)
*
|
2003-08-01 |
2005-02-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
|
|
BRPI0414536A
(pt)
*
|
2003-09-17 |
2006-11-07 |
Novartis Ag |
compostos orgánicos
|
|
CN1882327A
(zh)
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
|
US7470706B2
(en)
*
|
2004-01-31 |
2008-12-30 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
|
US7402674B2
(en)
*
|
2004-01-31 |
2008-07-22 |
Sanofi-Aventis Deutschland Gmbh, |
7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
|
US7498341B2
(en)
*
|
2004-01-31 |
2009-03-03 |
Sanofi Aventis Deutschland Gmbh |
Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
|
EP1586573B1
(en)
|
2004-04-01 |
2007-02-07 |
Sanofi-Aventis Deutschland GmbH |
Oxadiazolones, processes for their preparation and their use as pharmaceuticals
|
|
DE102004038403B4
(de)
*
|
2004-08-07 |
2006-08-31 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten
|
|
NZ552501A
(en)
*
|
2004-08-11 |
2010-03-26 |
Kyorin Seiyaku Kk |
Novel cyclic aminobenzoic acid derivative
|
|
DE102004039532B4
(de)
*
|
2004-08-14 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
DE102004039533B4
(de)
|
2004-08-14 |
2006-09-28 |
Sanofi-Aventis Deutschland Gmbh |
Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
DE102004039509B4
(de)
*
|
2004-08-14 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE102004040736B4
(de)
*
|
2004-08-23 |
2007-01-11 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung von Diarylcycloalkylderivaten
|
|
WO2006064189A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Astrazeneca Ab |
Oxadiazole derivatives as dgat inhibitors
|
|
EP1671633A1
(en)
*
|
2004-12-17 |
2006-06-21 |
Sanofi-Aventis Deutschland GmbH |
Use of PPAR agonists for the treatment of congestive heart failure
|
|
US20090036489A1
(en)
*
|
2005-03-22 |
2009-02-05 |
Masahiro Nomura |
Novel Cyclic Aminophenylalkanoic Acid Derivative
|
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
CN101272784A
(zh)
|
2005-09-29 |
2008-09-24 |
塞诺菲-安万特股份有限公司 |
苯基-和吡啶基-1,2,4-噁二唑酮衍生物、它们的制备方法和它们作为药物的用途
|
|
WO2007071966A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Pyrimido- [4, 5-b] -oxazines for use as dgat inhibitors
|
|
MX2008015228A
(es)
*
|
2006-05-30 |
2008-12-12 |
Astrazeneca Ab |
Acido 5-fenilamino-1,3,4-oxadiazol-2-ilcarbonilamino-4-fenoxi-cicl ohexanocarboxilico sustituido como inhibidor de diacilglicerol aciltransferasa de acetil coenzima a.
|
|
AU2007266890B2
(en)
*
|
2006-05-30 |
2011-02-17 |
Astrazeneca Ab |
1, 3, 4 -oxadiazole derivatives as DGAT1 inhibitors
|
|
CN101460492A
(zh)
*
|
2006-06-08 |
2009-06-17 |
阿斯利康(瑞典)有限公司 |
苯并咪唑及其治疗糖尿病的用途
|
|
GB0611507D0
(en)
*
|
2006-06-10 |
2006-07-19 |
Astrazeneca Ab |
Chemical compounds
|
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
|
DE102007002260A1
(de)
|
2007-01-16 |
2008-07-31 |
Sanofi-Aventis |
Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms
|
|
DE102007008420A1
(de)
|
2007-02-21 |
2008-08-28 |
Merck Patent Gmbh |
Benzimidazolderivate
|
|
US8058299B2
(en)
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
BRPI0811947A2
(pt)
*
|
2007-05-22 |
2014-11-11 |
Via Pharmaceuticals Inc |
Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratamento de obesidade, diabetes do tipo ii, dislipidemia ou síndrome metabólica
|
|
US8153644B2
(en)
|
2007-05-22 |
2012-04-10 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
US8115011B2
(en)
|
2007-05-22 |
2012-02-14 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
RU2010102990A
(ru)
*
|
2007-08-17 |
2011-09-27 |
Астразенека Аб (Se) |
Производные оксадиазолов в качестве ингибиторов dgat
|
|
CN101381302B
(zh)
*
|
2007-09-07 |
2013-04-03 |
上海睿智化学研究有限公司 |
2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
|
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
|
DE102007054497B3
(de)
*
|
2007-11-13 |
2009-07-23 |
Sanofi-Aventis Deutschland Gmbh |
Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
|
|
BRPI0821274A2
(pt)
|
2007-12-20 |
2017-06-13 |
Astrazeneca Ab |
composto ou um sal, ou pró-droga farmaceuticamente aceitável do mesmo, uso do mesmo, método para tratar uma doença em um animal de sangue quente, e, composição farmacêutica
|
|
DE102008017590A1
(de)
|
2008-04-07 |
2009-10-08 |
Merck Patent Gmbh |
Glucopyranosidderivate
|
|
TW201014822A
(en)
|
2008-07-09 |
2010-04-16 |
Sanofi Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
US8211884B2
(en)
*
|
2008-08-06 |
2012-07-03 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
US8324385B2
(en)
|
2008-10-30 |
2012-12-04 |
Madrigal Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
CN102239165A
(zh)
|
2008-12-03 |
2011-11-09 |
维尔制药公司 |
二酰甘油酰基转移酶抑制剂
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
CA2745445A1
(en)
|
2008-12-17 |
2010-07-08 |
Via Pharmaceuticals, Inc. |
Inhibitors of diacylglycerol aclytransferase
|
|
JP2012512860A
(ja)
*
|
2008-12-19 |
2012-06-07 |
アストラゼネカ アクチボラグ |
１，３，４−オキサジアゾール誘導体および糖尿病を処置するそれらの使用
|
|
WO2010093601A1
(en)
|
2009-02-10 |
2010-08-19 |
Metabasis Therapeutics, Inc. |
Novel sulfonic acid-containing thyromimetics, and methods for their use
|
|
RU2011152517A
(ru)
*
|
2009-06-19 |
2013-07-27 |
Астразенека Аб |
Пиразинкарбоксамиды в качестве ингибиторов dgat1
|
|
DK2470552T3
(en)
|
2009-08-26 |
2014-02-17 |
Sanofi Sa |
NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
|
|
EP2482823A2
(en)
|
2009-10-02 |
2012-08-08 |
Sanofi |
Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
WO2012120053A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8901114B2
(en)
|
2011-03-08 |
2014-12-02 |
Sanofi |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2018002215A1
(en)
*
|
2016-06-30 |
2018-01-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathies
|
